Paul F. Lizzul Anaptysbio, Inc (ANAB) insider trading activity

Paul F. Lizzul is Chief Medical Officer of ANAPTYSBIO, INC. Currently has a direct ownership of 33,303 shares of ANAB, which is worth approximately $1.13 Million. The most recent transaction as insider was on Jan 05, 2026, when has been sold 4,219 shares (Common Stock) at a price of $43.26 per share, resulting in proceeds of $182,513. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33.3K

29.87% 3M change

29.87% 12M change

Total Value Held $1.13 Million

Paul F. Lizzul Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 05 2026	SELL Open market or private sale	$182,513 $43.26 p/Share	4,219 Reduced 11.24%	33,303 Common Stock
Jan 03 2026	BUY Exercise of conversion of derivative security	-	10,555 Added 21.95%	37,522 Common Stock
Dec 22 2025	SELL Open market or private sale	$75,000 $50.0 p/Share	1,500 Reduced 5.27%	26,967 Common Stock
Dec 22 2025	BUY Exercise of conversion of derivative security	$27,750 $18.5 p/Share	1,500 Added 5.01%	28,467 Common Stock
Jan 06 2025	SELL Payment of exercise price or tax liability	$34,593 $15.3 p/Share	2,261 Reduced 8.1%	25,643 Common Stock
Jan 06 2025	BUY Exercise of conversion of derivative security	-	6,145 Added 18.05%	27,904 Common Stock
Jan 03 2025	SELL Payment of exercise price or tax liability	$63,305 $14.6 p/Share	4,336 Reduced 16.62%	21,759 Common Stock

Jan 03 2025	BUY Exercise of conversion of derivative security	-	10,555 Added 28.8%	26,095 Common Stock
Sep 23 2024	SELL Open market or private sale	$58,005 $38.67 p/Share	1,500 Reduced 8.88%	15,398 Common Stock
Sep 23 2024	BUY Exercise of conversion of derivative security	$27,750 $18.5 p/Share	1,500 Added 8.15%	16,898 Common Stock
Sep 16 2024	SELL Open market or private sale	$86,424 $38.93 p/Share	2,220 Reduced 12.6%	15,398 Common Stock
Sep 14 2024	BUY Exercise of conversion of derivative security	-	6,000 Added 25.4%	17,618 Common Stock
Aug 14 2024	SELL Open market or private sale	$80,000 $40.0 p/Share	2,000 Reduced 14.69%	11,618 Common Stock
Aug 14 2024	BUY Exercise of conversion of derivative security	$37,000 $18.5 p/Share	2,000 Added 12.81%	13,618 Common Stock
Jul 18 2024	SELL Open market or private sale	$52,500 $35.0 p/Share	1,500 Reduced 11.43%	11,618 Common Stock
Jul 18 2024	BUY Exercise of conversion of derivative security	$27,750 $18.5 p/Share	1,500 Added 10.26%	13,118 Common Stock
Jan 08 2024	SELL Open market or private sale	$55,702 $21.81 p/Share	2,554 Reduced 20.15%	10,118 Common Stock
Jan 06 2024	BUY Exercise of conversion of derivative security	-	6,145 Added 32.66%	12,672 Common Stock
Sep 14 2023	SELL Open market or private sale	$41,005 $19.48 p/Share	2,105 Reduced 24.39%	6,527 Common Stock
Sep 14 2023	BUY Exercise of conversion of derivative security	-	6,000 Added 41.01%	8,632 Common Stock
Nov 15 2021	BUY Grant, award, or other acquisition	$21,237 $22.03 p/Share	964 Added 50.0%	964 Common Stock

PFL

Paul F. Lizzul

Chief Medical Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANAB shares.

Notify only if

Value

Insider Trading

Get notified when an Anaptysbio, Inc insider buys or sells ANAB shares.

Notify only if

Operation

Value

Type

News

Receive news related to ANAPTYSBIO, INC

Track Activities on ANAB

Account